BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 342295)

  • 1. Comparative blanching activities of proprietary diflucortolone valerate topical preparations.
    Coleman GL; Kanfer I; Haigh JM
    Dermatologica; 1978; 156(4):224-30. PubMed ID: 342295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J; Renz F; Gasser D
    Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative blanching activities of locally manufactured proprietary fluocinolone acetonide topical preparations.
    Coleman GL; Magnus AD; Haigh JM; Kanfer I
    S Afr Med J; 1979 Sep; 56(11):447-9. PubMed ID: 399090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical treatment of dermatoses with difluocortolone valerate fatty ointment].
    Carvajal Rosado VM
    Z Hautkr; 1976; 51 Suppl 1():27-9. PubMed ID: 795183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Double-blind comparative study between difluocortolone-valerianate and fluocinolone-acetonide ointments].
    Capellini Gaya E
    Prensa Med Mex; 1977; 42(3-4):183-6. PubMed ID: 335382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part I: Comparative study of diflucortolone valerate with fluocortolone, -capronate, -pivalate in a double-blind contralateral design with topical application (author's transl)].
    Reckers VR; Wendt H
    Arzneimittelforschung; 1976; 26(7b):1499-504. PubMed ID: 795433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of a multi-center, international clinical trial of difluocortolone valerate (Nerisona)].
    Langen M; Hernandez MS
    Z Hautkr; 1976; 51 Suppl 1():1-16. PubMed ID: 795179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentric clinical trial with 0.1% diflucortolone valerate in Thailand.
    Bunyaratavej K; Hoppe G; Kotrajaras R; Rojananondh C; Siriyong D; Somprasong B; Tanprasert C; Vipakoon A; Vipulyasekha S
    J Med Assoc Thai; 1977 Aug; 60(8):353-61. PubMed ID: 908897
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of diflucortolone valerate in the vasoconstriction tests].
    Wendt VH; Reckers R
    Arzneimittelforschung; 1976; 26(7b):1495-8. PubMed ID: 1036946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part II: Comparative study with several commercial preparations (author's transl)].
    Reckers VR; Wendt H
    Arzneimittelforschung; 1976; 26(7b):1504-9. PubMed ID: 795434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diflucortolone valerate. Asian experience.
    Hoppe G
    Drugs; 1988; 36 Suppl 5():24-33. PubMed ID: 3254827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diflucortolone valerianate (Nerisona) in the treatment of corticoid-sensitive dermatoses in childhood].
    Langen ML; Psenicka FG
    Z Hautkr; 1977 Dec; 52(24):1244-52. PubMed ID: 341552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical formulations of fluocinolone acetonide. Are creams, gels and ointments bioequivalent and does dilution affect activity?
    Gao HY; Li Wan Po A
    Eur J Clin Pharmacol; 1994; 46(1):71-5. PubMed ID: 8005190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Difluocortolone valerate for topical use in dermatology].
    Consigli CA; González W
    Z Hautkr; 1976; 51 Suppl 1():30-2. PubMed ID: 795184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical comparative study of between difluocortolone and flumethasone].
    Soto JM; Villalba Pimentel L; Alvarado Romero J
    Med Cutan Ibero Lat Am; 1977; 5(4):267-70. PubMed ID: 364210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the potencies of several diluted and undiluted corticosteroid preparations using the vasoconstrictor assay.
    Kirsch J; Gibson JR; Darley CR; Burke CA
    Dermatologica; 1983; 167(3):138-41. PubMed ID: 6195026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biologic availability of diflucortolone-21-valerate in human skin].
    Täuber U
    Arzneimittelforschung; 1983; 33(10):1503-7. PubMed ID: 6686053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies on Bi-Nerisona cream (diflucortolone valerinate + chlorquinaldol) and on a combination preparation (betamethasone valerinate + gentamicin + tolnaftate + clioquinol) in a double-blind trial].
    Hernández MS
    Z Hautkr; 1978 Jul; 53(13):453-8. PubMed ID: 150142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Difluocortolone valerate: a new corticoid for topical use].
    Caferri de Paolini MI
    Z Hautkr; 1976; 51 Suppl 1():23-6. PubMed ID: 795182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Difluocortolone valerate in dermatology].
    Azar A
    Z Hautkr; 1976; 51 Suppl 1():20-2. PubMed ID: 795181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.